J. Jay Lobell - 01 Jan 2026 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Reporting relationship: Director
Issuer ticker: FBIO
Reported as of: 01 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 16:30:26 UTC
Prior SEC filing: 03 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Samuel Berry, Attorney-in-Fact

Key filing fact

J. Jay Lobell filed Form 4 for Fortress Biotech, Inc. (FBIO) on 05 Jan 2026.

Key facts

This page summarizes J. Jay Lobell's Form 4 filing for Fortress Biotech, Inc. (FBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jan 2026, 16:30.

Change

Previous filing in this sequence was filed on 03 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001172659 Primary reporting owner

LOBELL J JAY

Relationship: Director
Address: C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS
Signature: /s/ Samuel Berry, Attorney-in-Fact
Signature date: 05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBIO transaction

common stock, par value $0.001

Award

Transaction value: $0
Shares: +27,322
Change %: +17%
Price: $0.000000
Shares after: 192,397
Date: 01 Jan 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.

Footnote F2

Total holdings include 76,705 shares underlying deferred restricted stock units.